Keith Alexander — CFO

Get alerts when Keith Alexander trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: ExpreS2ion Biotech Holding AB.

12-month summary

No open-market buys or sales in the last 12 months

0 open-market buys, 0 sales, 1 share award

Roles

02.10.2025 – 01.07.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
01.07.2026ExpreS2ion Biotech Holding AB Stockholm
Share award
225,615—
Share award
225,615 units
↗
30.04.2026ExpreS2ion Biotech Holding AB Stockholm
New shares (subscription)
12,500SEK 1.60
SEK 20,000.00
↗
02.10.2025ExpreS2ion Biotech Holding AB Stockholm
Option exercise
250SEK 14.65
SEK 3,662.50
↗
02.10.2025ExpreS2ion Biotech Holding AB Stockholm
Option exercise
10,000SEK 14.65
SEK 146,500.00
↗